Earlier and recent reports have demonstrated that CCN1 is expressed in MM myeloid and lymphoid cells, as well as other tumor cells such as breast and prostate cancer, and may contribute to tumor cell survival by providing signals stimulating angiogenesis and survival through acquire anoikis resistance[14,44,46-48]. Here, CCN1 is linked to Miyoshi myopathy.